Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Bode

Showing results (571-580 of 589) with videos related to

Pageof 59
Sort By:
Diabetes Research and Clinical Practice|July 19, 2022
How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 SystemWilliam H Polonsky, Korey K Hood, Carol J Levy, et al.
Diabetes Technology & Therapeutics|March 9, 2022
Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal TrialRon Brazg, Satish K Garg, Anuj Bhargava, et al.
Diabetes Technology & Therapeutics|October 18, 2023
Two Years with a Tubeless Automated Insulin Delivery System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 DiabetesAmy B Criego, Anders L Carlson, Sue A Brown, et al.
Diabetes Care|June 8, 2021
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 DiabetesSue A Brown, Gregory P Forlenza, Bruce W Bode, et al.
Diabetes Technology & Therapeutics|October 2, 2023
Safety and Glycemic Outcomes During the MiniMed<sup>TM</sup> Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 DiabetesCatherine Pihoker, Dorothy I Shulman, Gregory P Forlenza, et al.
The New England Journal of Medicine|September 10, 2008
Continuous glucose monitoring and intensive treatment of type 1 diabetes, William V Tamborlane, Roy W Beck, et al.
Diabetes Care|May 12, 2009
The effect of continuous glucose monitoring in well-controlled type 1 diabetes, Roy W Beck, Irl B Hirsch, et al.
Diabetes Technology & Therapeutics|October 25, 2021
Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 DiabetesAnders L Carlson, Jennifer L Sherr, Dorothy I Shulman, et al.
Diabetes Technology & Therapeutics|December 16, 2020
First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 DiabetesGregory P Forlenza, Bruce A Buckingham, Sue A Brown, et al.
JAMA|June 17, 2020
Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical TrialRichard E Pratley, Lauren G Kanapka, Michael R Rickels, et al.
Pageof 59

Showing results (571-580 of 589) with videos related to

Sort By:
Pageof 59
Diabetes Research and Clinical Practice|July 19, 2022
How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 SystemWilliam H Polonsky, Korey K Hood, Carol J Levy, et al.
Diabetes Technology & Therapeutics|March 9, 2022
Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal TrialRon Brazg, Satish K Garg, Anuj Bhargava, et al.
Diabetes Technology & Therapeutics|October 18, 2023
Two Years with a Tubeless Automated Insulin Delivery System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 DiabetesAmy B Criego, Anders L Carlson, Sue A Brown, et al.
Diabetes Care|June 8, 2021
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 DiabetesSue A Brown, Gregory P Forlenza, Bruce W Bode, et al.
Diabetes Technology & Therapeutics|October 2, 2023
Safety and Glycemic Outcomes During the MiniMed<sup>TM</sup> Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 DiabetesCatherine Pihoker, Dorothy I Shulman, Gregory P Forlenza, et al.
The New England Journal of Medicine|September 10, 2008
Continuous glucose monitoring and intensive treatment of type 1 diabetes, William V Tamborlane, Roy W Beck, et al.
Diabetes Care|May 12, 2009
The effect of continuous glucose monitoring in well-controlled type 1 diabetes, Roy W Beck, Irl B Hirsch, et al.
Diabetes Technology & Therapeutics|October 25, 2021
Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 DiabetesAnders L Carlson, Jennifer L Sherr, Dorothy I Shulman, et al.
Diabetes Technology & Therapeutics|December 16, 2020
First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 DiabetesGregory P Forlenza, Bruce A Buckingham, Sue A Brown, et al.
JAMA|June 17, 2020
Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical TrialRichard E Pratley, Lauren G Kanapka, Michael R Rickels, et al.
Pageof 59